Job Opportunities
Find jobs near you, whether onsite, hybrid, or remote.- Similar Jobs to: Principal Formulation Development Scientist I - Oxford
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited Kingdom
Principal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreHenley on ThamesPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreBourton on the WaterPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreRoushamPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreStratfield SayePrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
